CN Patent
CN102970983A — 耐受酒精的口服药物制剂
Assigned to Ethypharm SAS · Expires 2013-03-13 · 13y expired
What this patent protects
本发明涉及一种新型口服药物组合物,其对归因于酒精的活性成分剂量的迅速释放耐受,并且其允许每天摄入一个单一剂量。
USPTO Abstract
本发明涉及一种新型口服药物组合物,其对归因于酒精的活性成分剂量的迅速释放耐受,并且其允许每天摄入一个单一剂量。
Drugs covered by this patent
- Pulmicort Respules (BUDESONIDE) · AstraZeneca K.K.
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.